> top > docs > PMC:400732 > spans > 5302-6327 > annotations

PMC:400732 / 5302-6327 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T1628 0-5 IN denotes While
T1629 32-36 VBN denotes used
T1630 6-9 NN denotes D2R
T1631 10-21 NNS denotes antagonists
T1632 22-26 VBP denotes have
T1633 27-31 VBN denotes been
T1634 182-191 VBN denotes prevented
T1635 37-39 IN denotes in
T1636 40-43 DT denotes the
T1637 44-51 NN denotes context
T1638 52-54 IN denotes of
T1639 55-61 NN denotes rodent
T1640 83-92 NNS denotes paradigms
T1641 62-73 JJ denotes associative
T1642 74-82 NN denotes learning
T1643 92-94 , denotes ,
T1644 94-99 PRP$ denotes their
T1645 100-104 NN denotes lack
T1646 105-107 IN denotes of
T1647 108-116 NN denotes receptor
T1648 117-124 NN denotes subtype
T1649 125-136 NN denotes specificity
T1650 137-138 -LRB- denotes [
T1651 138-140 CD denotes 13
T1652 140-141 -RRB- denotes ]
T1653 142-145 CC denotes and
T1654 146-151 NN denotes motor
T1655 152-162 VBG denotes disrupting
T1656 151-152 HYPH denotes -
T1657 163-170 NNS denotes effects
T1658 171-172 -LRB- denotes [
T1659 174-175 CD denotes 8
T1660 172-173 CD denotes 6
T1661 173-174 , denotes ,
T1662 175-176 -RRB- denotes ]
T1663 177-181 VBP denotes have
T1664 192-193 DT denotes a
T1665 203-214 NN denotes examination
T1666 194-202 JJ denotes rigorous
T1667 215-217 IN denotes of
T1668 218-221 DT denotes the
T1669 229-233 NN denotes role
T1670 222-228 JJ denotes actual
T1671 234-238 DT denotes this
T1672 257-264 NN denotes subtype
T1673 239-247 NN denotes dopamine
T1674 248-256 NN denotes receptor
T1675 265-270 VBZ denotes plays
T1676 271-273 IN denotes in
T1677 274-285 JJ denotes associative
T1678 299-307 NN denotes learning
T1679 286-289 CC denotes and
T1680 290-298 JJ denotes reversal
T1681 308-310 IN denotes in
T1682 311-314 DT denotes the
T1683 315-322 NN denotes context
T1684 323-325 IN denotes of
T1685 326-328 DT denotes an
T1686 337-345 NN denotes behavior
T1687 329-336 NN denotes operant
T1688 345-346 . denotes .
T1689 346-687 sentence denotes Past experiments seeking to explore the possible involvement of dopamine D2Rs in associative learning have utilized low to moderate doses of drugs [2,5,6] and site-specific administration [7,9] in order to avoid the confounding effect that locomotor disruption associated with acute D2R blockade can have on learning performance in rodents.
T1690 347-351 JJ denotes Past
T1691 352-363 NNS denotes experiments
T1692 454-462 VBN denotes utilized
T1693 364-371 VBG denotes seeking
T1694 372-374 TO denotes to
T1695 375-382 VB denotes explore
T1696 383-386 DT denotes the
T1697 396-407 NN denotes involvement
T1698 387-395 JJ denotes possible
T1699 408-410 IN denotes of
T1700 411-419 NN denotes dopamine
T1701 420-424 NNS denotes D2Rs
T1702 425-427 IN denotes in
T1703 428-439 JJ denotes associative
T1704 440-448 NN denotes learning
T1705 449-453 VBP denotes have
T1706 463-466 JJ denotes low
T1707 479-484 NNS denotes doses
T1708 467-469 IN denotes to
T1709 470-478 JJ denotes moderate
T1710 485-487 IN denotes of
T1711 488-493 NNS denotes drugs
T1712 494-495 -LRB- denotes [
T1713 499-500 CD denotes 6
T1714 495-496 CD denotes 2
T1715 496-497 , denotes ,
T1716 497-498 CD denotes 5
T1717 498-499 , denotes ,
T1718 500-501 -RRB- denotes ]
T1719 502-505 CC denotes and
T1720 506-510 NN denotes site
T1721 511-519 JJ denotes specific
T1722 510-511 HYPH denotes -
T1723 520-534 NN denotes administration
T1724 535-536 -LRB- denotes [
T1725 538-539 CD denotes 9
T1726 536-537 CD denotes 7
T1727 537-538 , denotes ,
T1728 539-540 -RRB- denotes ]
T1729 541-543 IN denotes in
T1730 544-549 NN denotes order
T1731 550-552 TO denotes to
T1732 553-558 VB denotes avoid
T1733 559-562 DT denotes the
T1734 575-581 NN denotes effect
T1735 563-574 VBG denotes confounding
T1736 582-586 WDT denotes that
T1737 647-651 VB denotes have
T1738 587-596 NN denotes locomotor
T1739 597-607 NN denotes disruption
T1740 608-618 VBN denotes associated
T1741 619-623 IN denotes with
T1742 624-629 JJ denotes acute
T1743 634-642 NN denotes blockade
T1744 630-633 NN denotes D2R
T1745 643-646 MD denotes can
T1746 652-654 IN denotes on
T1747 655-663 NN denotes learning
T1748 664-675 NN denotes performance
T1749 676-678 IN denotes in
T1750 679-686 NNS denotes rodents
T1751 686-687 . denotes .
T1752 687-868 sentence denotes Besides their lack of receptor subtype specificity, an acute exposure to commercially available D2 receptor antagonists fails to completely block signaling mediated solely by D2Rs.
T1753 688-695 IN denotes Besides
T1754 808-813 VBZ denotes fails
T1755 696-701 PRP$ denotes their
T1756 702-706 NN denotes lack
T1757 707-709 IN denotes of
T1758 710-718 NN denotes receptor
T1759 719-726 NN denotes subtype
T1760 727-738 NN denotes specificity
T1761 738-740 , denotes ,
T1762 740-742 DT denotes an
T1763 749-757 NN denotes exposure
T1764 743-748 JJ denotes acute
T1765 758-760 IN denotes to
T1766 761-773 RB denotes commercially
T1767 774-783 JJ denotes available
T1768 796-807 NNS denotes antagonists
T1769 784-786 NN denotes D2
T1770 787-795 NN denotes receptor
T1771 814-816 TO denotes to
T1772 828-833 VB denotes block
T1773 817-827 RB denotes completely
T1774 834-843 NN denotes signaling
T1775 844-852 VBN denotes mediated
T1776 853-859 RB denotes solely
T1777 860-862 IN denotes by
T1778 863-867 NNS denotes D2Rs
T1779 867-868 . denotes .
T1780 868-1025 sentence denotes Moreover, acute dosing does not recapitulate the marked learning deficits produced in rodents [15,16] by chronic exposure to dopamine D2R antagonists [6,7].
T1781 869-877 RB denotes Moreover
T1782 901-913 VB denotes recapitulate
T1783 877-879 , denotes ,
T1784 879-884 JJ denotes acute
T1785 885-891 NN denotes dosing
T1786 892-896 VBZ denotes does
T1787 897-900 RB denotes not
T1788 914-917 DT denotes the
T1789 934-942 NNS denotes deficits
T1790 918-924 JJ denotes marked
T1791 925-933 NN denotes learning
T1792 943-951 VBN denotes produced
T1793 952-954 IN denotes in
T1794 955-962 NNS denotes rodents
T1795 963-964 -LRB- denotes [
T1796 967-969 CD denotes 16
T1797 964-966 CD denotes 15
T1798 966-967 , denotes ,
T1799 969-970 -RRB- denotes ]
T1800 971-973 IN denotes by
T1801 974-981 JJ denotes chronic
T1802 982-990 NN denotes exposure
T1803 991-993 IN denotes to
T1804 994-1002 NN denotes dopamine
T1805 1003-1006 NN denotes D2R
T1806 1007-1018 NNS denotes antagonists
T1807 1019-1020 -LRB- denotes [
T1808 1022-1023 CD denotes 7
T1809 1020-1021 CD denotes 6
T1810 1021-1022 , denotes ,
T1811 1023-1024 -RRB- denotes ]
T1812 1024-1025 . denotes .
R895 T1628 T1629 mark While,used
R896 T1629 T1634 advcl used,prevented
R897 T1630 T1631 compound D2R,antagonists
R898 T1631 T1629 nsubjpass antagonists,used
R899 T1632 T1629 aux have,used
R900 T1633 T1629 auxpass been,used
R901 T1635 T1629 prep in,used
R902 T1636 T1637 det the,context
R903 T1637 T1635 pobj context,in
R904 T1638 T1637 prep of,context
R905 T1639 T1640 nmod rodent,paradigms
R906 T1640 T1638 pobj paradigms,of
R907 T1641 T1642 amod associative,learning
R908 T1642 T1640 compound learning,paradigms
R909 T1643 T1634 punct ", ",prevented
R910 T1644 T1645 poss their,lack
R911 T1645 T1634 nsubj lack,prevented
R912 T1646 T1645 prep of,lack
R913 T1647 T1648 compound receptor,subtype
R914 T1648 T1649 compound subtype,specificity
R915 T1649 T1646 pobj specificity,of
R916 T1650 T1651 punct [,13
R917 T1651 T1649 parataxis 13,specificity
R918 T1652 T1651 punct ],13
R919 T1653 T1649 cc and,specificity
R920 T1654 T1655 npadvmod motor,disrupting
R921 T1655 T1657 amod disrupting,effects
R922 T1656 T1655 punct -,disrupting
R923 T1657 T1649 conj effects,specificity
R924 T1658 T1659 punct [,8
R925 T1659 T1657 parataxis 8,effects
R926 T1660 T1659 nummod 6,8
R927 T1661 T1659 punct ",",8
R928 T1662 T1659 punct ],8
R929 T1663 T1634 aux have,prevented
R930 T1664 T1665 det a,examination
R931 T1665 T1634 dobj examination,prevented
R932 T1666 T1665 amod rigorous,examination
R933 T1667 T1665 prep of,examination
R934 T1668 T1669 det the,role
R935 T1669 T1667 pobj role,of
R936 T1670 T1669 amod actual,role
R937 T1671 T1672 det this,subtype
R938 T1672 T1675 nsubj subtype,plays
R939 T1673 T1674 compound dopamine,receptor
R940 T1674 T1672 compound receptor,subtype
R941 T1675 T1669 advcl plays,role
R942 T1676 T1675 prep in,plays
R943 T1677 T1678 amod associative,learning
R944 T1678 T1676 pobj learning,in
R945 T1679 T1677 cc and,associative
R946 T1680 T1677 conj reversal,associative
R947 T1681 T1675 prep in,plays
R948 T1682 T1683 det the,context
R949 T1683 T1681 pobj context,in
R950 T1684 T1683 prep of,context
R951 T1685 T1686 det an,behavior
R952 T1686 T1684 pobj behavior,of
R953 T1687 T1686 compound operant,behavior
R954 T1688 T1634 punct .,prevented
R955 T1690 T1691 amod Past,experiments
R956 T1691 T1692 nsubj experiments,utilized
R957 T1693 T1691 acl seeking,experiments
R958 T1694 T1695 aux to,explore
R959 T1695 T1693 xcomp explore,seeking
R960 T1696 T1697 det the,involvement
R961 T1697 T1695 dobj involvement,explore
R962 T1698 T1697 amod possible,involvement
R963 T1699 T1697 prep of,involvement
R964 T1700 T1701 compound dopamine,D2Rs
R965 T1701 T1699 pobj D2Rs,of
R966 T1702 T1697 prep in,involvement
R967 T1703 T1704 amod associative,learning
R968 T1704 T1702 pobj learning,in
R969 T1705 T1692 aux have,utilized
R970 T1706 T1707 amod low,doses
R971 T1707 T1692 dobj doses,utilized
R972 T1708 T1706 prep to,low
R973 T1709 T1708 amod moderate,to
R974 T1710 T1707 prep of,doses
R975 T1711 T1710 pobj drugs,of
R976 T1712 T1713 punct [,6
R977 T1713 T1707 parataxis 6,doses
R978 T1714 T1713 nummod 2,6
R979 T1715 T1713 punct ",",6
R980 T1716 T1713 nummod 5,6
R981 T1717 T1713 punct ",",6
R982 T1718 T1713 punct ],6
R983 T1719 T1707 cc and,doses
R984 T1720 T1721 npadvmod site,specific
R985 T1721 T1723 amod specific,administration
R986 T1722 T1721 punct -,specific
R987 T1723 T1707 conj administration,doses
R988 T1724 T1725 punct [,9
R989 T1725 T1723 parataxis 9,administration
R990 T1726 T1725 nummod 7,9
R991 T1727 T1725 punct ",",9
R992 T1728 T1725 punct ],9
R993 T1729 T1692 prep in,utilized
R994 T1730 T1729 pobj order,in
R995 T1731 T1732 aux to,avoid
R996 T1732 T1730 acl avoid,order
R997 T1733 T1734 det the,effect
R998 T1734 T1732 dobj effect,avoid
R999 T1735 T1734 amod confounding,effect
R1000 T1736 T1737 dep that,have
R1001 T1737 T1734 relcl have,effect
R1002 T1738 T1739 compound locomotor,disruption
R1003 T1739 T1737 nsubj disruption,have
R1004 T1740 T1739 acl associated,disruption
R1005 T1741 T1740 prep with,associated
R1006 T1742 T1743 amod acute,blockade
R1007 T1743 T1741 pobj blockade,with
R1008 T1744 T1743 compound D2R,blockade
R1009 T1745 T1737 aux can,have
R1010 T1746 T1737 prep on,have
R1011 T1747 T1748 compound learning,performance
R1012 T1748 T1746 pobj performance,on
R1013 T1749 T1737 prep in,have
R1014 T1750 T1749 pobj rodents,in
R1015 T1751 T1692 punct .,utilized
R1016 T1753 T1754 prep Besides,fails
R1017 T1755 T1756 poss their,lack
R1018 T1756 T1753 pobj lack,Besides
R1019 T1757 T1756 prep of,lack
R1020 T1758 T1759 compound receptor,subtype
R1021 T1759 T1760 compound subtype,specificity
R1022 T1760 T1757 pobj specificity,of
R1023 T1761 T1754 punct ", ",fails
R1024 T1762 T1763 det an,exposure
R1025 T1763 T1754 nsubj exposure,fails
R1026 T1764 T1763 amod acute,exposure
R1027 T1765 T1763 prep to,exposure
R1028 T1766 T1767 advmod commercially,available
R1029 T1767 T1768 amod available,antagonists
R1030 T1768 T1765 pobj antagonists,to
R1031 T1769 T1770 compound D2,receptor
R1032 T1770 T1768 compound receptor,antagonists
R1033 T1771 T1772 aux to,block
R1034 T1772 T1754 xcomp block,fails
R1035 T1773 T1772 advmod completely,block
R1036 T1774 T1772 dobj signaling,block
R1037 T1775 T1774 acl mediated,signaling
R1038 T1776 T1775 advmod solely,mediated
R1039 T1777 T1775 agent by,mediated
R1040 T1778 T1777 pobj D2Rs,by
R1041 T1779 T1754 punct .,fails
R1042 T1781 T1782 advmod Moreover,recapitulate
R1043 T1783 T1782 punct ", ",recapitulate
R1044 T1784 T1785 amod acute,dosing
R1045 T1785 T1782 nsubj dosing,recapitulate
R1046 T1786 T1782 aux does,recapitulate
R1047 T1787 T1782 neg not,recapitulate
R1048 T1788 T1789 det the,deficits
R1049 T1789 T1782 dobj deficits,recapitulate
R1050 T1790 T1789 amod marked,deficits
R1051 T1791 T1789 compound learning,deficits
R1052 T1792 T1789 acl produced,deficits
R1053 T1793 T1792 prep in,produced
R1054 T1794 T1793 pobj rodents,in
R1055 T1795 T1796 punct [,16
R1056 T1796 T1792 parataxis 16,produced
R1057 T1797 T1796 nummod 15,16
R1058 T1798 T1796 punct ",",16
R1059 T1799 T1796 punct ],16
R1060 T1800 T1792 agent by,produced
R1061 T1801 T1802 amod chronic,exposure
R1062 T1802 T1800 pobj exposure,by
R1063 T1803 T1802 prep to,exposure
R1064 T1804 T1805 compound dopamine,D2R
R1065 T1805 T1806 compound D2R,antagonists
R1066 T1806 T1803 pobj antagonists,to
R1068 T1807 T1808 punct [,7
R1070 T1808 T1792 parataxis 7,produced
R1072 T1809 T1808 nummod 6,7
R1075 T1810 T1808 punct ",",7
R1078 T1811 T1808 punct ],7
R1082 T1812 T1782 punct .,recapitulate

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T1027 6-9 PR_EXT:000001177 denotes D2R
T1028 10-21 CHEBI_GO_EXT:antagonist denotes antagonists
T1029 55-61 NCBITaxon:9989 denotes rodent
T1030 62-82 GO:0008306 denotes associative learning
T1031 108-116 GO_EXT:0004872 denotes receptor
T1032 146-151 GO_EXT:biological_movement_or_translocation_process denotes motor
T1033 239-247 CHEBI:18243 denotes dopamine
T1034 239-256 GO_EXT:0004952 denotes dopamine receptor
T1035 274-285 _FRAGMENT denotes associative
T1036 299-307 GO:0008306 denotes learning
T1037 337-345 GO_PATO_EXT:biological_behavior denotes behavior
T1038 411-419 CHEBI:18243 denotes dopamine
T1039 411-424 PR_EXT:000001177 denotes dopamine D2Rs
T1040 428-448 GO:0008306 denotes associative learning
T1041 488-493 CHEBI_EXT:23888 denotes drugs
T1042 587-596 GO:0040011 denotes locomotor
T1043 630-633 PR_EXT:000001177 denotes D2R
T1044 655-663 GO:0007612 denotes learning
T1045 679-686 NCBITaxon:9989 denotes rodents
T1046 710-718 GO_EXT:0004872 denotes receptor
T1047 784-795 PR_EXT:000001177 denotes D2 receptor
T1048 787-795 GO_EXT:0004872 denotes receptor
T1049 796-807 CHEBI_GO_EXT:antagonist denotes antagonists
T1050 834-843 GO_EXT:cell_communication_or_signaling_or_signal_transduction denotes signaling
T1051 863-867 PR_EXT:000001177 denotes D2Rs
T1052 925-933 GO:0007612 denotes learning
T1053 955-962 NCBITaxon:9989 denotes rodents
T1054 994-1006 PR_EXT:000001177 denotes dopamine D2R
T1055 994-1002 _FRAGMENT denotes dopamine
T1056 1007-1018 CHEBI_EXT:48561 denotes antagonists
T1057 1007-1018 CHEBI_GO_EXT:antagonist denotes antagonists
R402 T1036 T1035 _lexicallyChainedTo learning,associative
R403 T1056 T1055 _lexicallyChainedTo antagonists,dopamine

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T887 6-9 PR:000001177 denotes D2R
T888 55-61 NCBITaxon:9989 denotes rodent
T889 62-82 GO:0008306 denotes associative learning
T890 239-247 CHEBI:18243 denotes dopamine
T891 274-285 _FRAGMENT denotes associative
T892 299-307 GO:0008306 denotes learning
T893 411-419 CHEBI:18243 denotes dopamine
T894 411-424 PR:000001177 denotes dopamine D2Rs
T895 428-448 GO:0008306 denotes associative learning
T896 488-493 CHEBI:23888 denotes drugs
T897 587-596 GO:0040011 denotes locomotor
T898 630-633 PR:000001177 denotes D2R
T899 655-663 GO:0007612 denotes learning
T900 679-686 NCBITaxon:9989 denotes rodents
T901 784-795 PR:000001177 denotes D2 receptor
T902 863-867 PR:000001177 denotes D2Rs
T903 925-933 GO:0007612 denotes learning
T904 955-962 NCBITaxon:9989 denotes rodents
T905 994-1006 PR:000001177 denotes dopamine D2R
T906 994-1002 _FRAGMENT denotes dopamine
T907 1007-1018 CHEBI:48561 denotes antagonists
R396 T892 T891 _lexicallyChainedTo learning,associative
R397 T907 T906 _lexicallyChainedTo antagonists,dopamine

2_test

Id Subject Object Predicate Lexical cue
15061865-12629161-12857708 172-173 12629161 denotes 6
15061865-12445722-12857709 174-175 12445722 denotes 8
15061865-12445713-12857710 495-496 12445713 denotes 2
15061865-11919664-12857711 497-498 11919664 denotes 5
15061865-12629161-12857712 499-500 12629161 denotes 6
15061865-11027236-12857713 536-537 11027236 denotes 7
15061865-11351937-12857714 538-539 11351937 denotes 9
15061865-12457265-12857715 964-966 12457265 denotes 15
15061865-12589383-12857716 967-969 12589383 denotes 16
15061865-12629161-12857717 1020-1021 12629161 denotes 6
15061865-11027236-12857718 1022-1023 11027236 denotes 7